Tolera Therapeutics, Inc
1 clinical trials · Sponsor
◉ Watch Tolera Therapeutics, Inc
| Record | Firm | Date |
|---|---|---|
| Evaluating Safety and Efficacy of TOL101 Induction Versus Anti-Thymocyte Globulin to Prevent Kidney Transplant Rejection (NCT01154387) | Tolera Therapeutics, Inc | 2010-07-01 |
Track Tolera Therapeutics, Inc automatically
Every clearance here is in the API, with alerts when new ones post.